FFA
ATYR

Farther Finance Advisors’s aTyr Pharma ATYR Stock Holding History

Farther Finance Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Sell
1,320
-905
-41% -$764 ﹤0.01% 5078
2025
Q4 		$1.74K Buy
2,225
+125
+6% +$103 ﹤0.01% 4743
2025
Q3 		$1.51K Sell
2,100
-17,823
-89% -$80.8K ﹤0.01% 4237
2025
Q2 		$101K Sell
19,923
-4,500
-18% -$17.7K ﹤0.01% 1760
2025
Q1 		$70.3K Hold
24,423
– – ﹤0.01% 1705
2024
Q4 		$88.4K Sell
24,423
-9,000
-27% -$27.3K ﹤0.01% 1359
2024
Q3 		$58.8K Buy
33,423
+3,000
+10% +$5.46K ﹤0.01% 1564
2024
Q2 		$47.5K Buy
30,423
+100
+0.3% +$174 ﹤0.01% 1443
2024
Q1 		$57.9K Hold
30,323
– – ﹤0.01% 1131
2023
Q4 		$42.8K Buy
+30,323
New +$38.9K ﹤0.01% 1093

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return